Skip to main content
. Author manuscript; available in PMC: 2009 Aug 31.
Published in final edited form as: J Immunol. 2008 Jul 1;181(1):610–620. doi: 10.4049/jimmunol.181.1.610

Figure 3.

Figure 3

Kinetics of total lung cDC accumulation in CCR2+/+ and CCR2−/− mice following infection with C. neoformans. CCR2+/+ and CCR2−/− mice were infected with C. neoformans; total lung digests (without BAL) were performed on mice at days 0 (uninfected) and 3, 7, 10, 14, 21, and 28 post-infection. (A) Kinetics of total lung leukocyte (CD45+) accumulation. (B) cDC (elliptical gates) were identified using the gating strategy outlined in the Methods section and in the legend to Figure 2. Representative scatter plots (x-axis, I-Ad; y-axis CD11c) of cDC in the lungs of either CCR2+/+ mice (left panels) or CCR2−/− mice (right panels) at day 0 (D0; top panels) or 10 (D10; bottom panels) post-IT infection with C. neoformans. (C) Frequency of lung cDC (% of CD45+ cells) throughout the observed time course. (D) Numbers of total lung cDC (Total leukocytes × frequency of cDC) throughout the observed time course. CCR2+/+, black line or bar; CCR2−/− mice, dashed gray line or bar. Data represents a mean ± SEM of 4–7 mice assayed individually per time-point in 2–3 experiments; * p<0.05 ANOVA with Dunnet's post-hoc analysis vs. Day 0 (uninfected) of mice of the same CCR2 expression profile, ‡p<0.05 by unpaired student t-test when values from CCR2+/+ mice or CCR2−/− mice were compared against each other at the designated time point.

HHS Vulnerability Disclosure